Novel targets in renal fibrosis based on bioinformatic analysis

Yuan Yuan1, Xi Xiong2, Lili Li3

  • 1Department of Urology, Wuhan Third Hospital and Tongren Hospital of Wuhan University, Wuhan, China.

Frontiers in Genetics
|December 16, 2022
PubMed

Insights

Researchers identified five key genes (Bmp1, CD74, Fcer1g, Icam1, H2-Eb1) that could serve as biomarkers for chronic kidney disease (CKD) progression. This study establishes a gene network for understanding CKD transcriptome signatures.

Area of Science:

  • Genomics and Bioinformatics
  • Renal Pathophysiology

Background:

  • Renal fibrosis is a critical indicator of progressive chronic kidney disease (CKD), representing a common final pathway for many renal diseases.
  • The specific genes involved in the host response during renal fibrosis remain largely undefined.

Purpose of the Study:

  • To investigate the gene network, signaling pathways, and key genes associated with renal fibrosis using a unilateral ureteral obstruction (UUO) mouse model.
  • To identify potential diagnostic and therapeutic biomarkers for CKD.

Main Methods:

  • Integration of two transcriptome datasets from mouse kidneys following UUO surgery.
  • Identification of differentially expressed genes (DEGs), followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis.
  • Construction of a Protein-Protein Interaction (PPI) network to identify hub genes, with validation using public datasets and quantitative real-time PCR (qRT-PCR).

Main Results:

  • A total of 537 DEGs were common across both datasets.
  • Enrichment analysis revealed significant involvement of DEGs in seven key pathways.
  • Five hub genes (Bmp1, CD74, Fcer1g, Icam1, H2-Eb1) were identified and demonstrated potential as biomarkers via ROC curve analysis.

Conclusions:

  • A comprehensive gene network reflecting the transcriptome signature of CKD was successfully established.
  • The identified five hub genes hold significant potential as biomarkers for the diagnosis and treatment of CKD.